vs
Cytek Biosciences, Inc.（CTKB）与合众银行（OSBC）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是Cytek Biosciences, Inc.的1.5倍（$93.8M vs $62.1M），合众银行净利率更高（27.3% vs -70.9%，领先98.2%），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 15.1%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
合众银行是一家总部位于美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押等金融服务。
CTKB vs OSBC — 直观对比
营收规模更大
OSBC
是对方的1.5倍
$62.1M
净利率更高
OSBC
高出98.2%
-70.9%
两年增速更快
CTKB
近两年复合增速
15.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $93.8M |
| 净利润 | $-44.1M | $25.6M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | — |
| 净利率 | -70.9% | 27.3% |
| 营收同比 | 8.1% | — |
| 净利润同比 | -557.1% | 159.2% |
| 每股收益（稀释后） | — | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBOSBC
| Q1 26 | — | $93.8M | ||
| Q4 25 | $62.1M | $95.2M | ||
| Q3 25 | $52.3M | $95.9M | ||
| Q2 25 | $45.6M | $75.1M | ||
| Q1 25 | $41.5M | $73.1M | ||
| Q4 24 | $57.5M | $73.2M | ||
| Q3 24 | $51.5M | $71.2M | ||
| Q2 24 | $46.6M | $70.8M |
净利润CTKBOSBC
| Q1 26 | — | $25.6M | ||
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $9.9M | ||
| Q2 25 | $-5.6M | $21.8M | ||
| Q1 25 | $-11.4M | $19.8M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $23.0M | ||
| Q2 24 | $-10.4M | $21.9M |
毛利率CTKBOSBC
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
营业利润率CTKBOSBC
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 41.2% | ||
| Q3 25 | -17.6% | 13.6% | ||
| Q2 25 | -23.3% | 38.9% | ||
| Q1 25 | -36.1% | 35.8% | ||
| Q4 24 | 5.2% | 34.7% | ||
| Q3 24 | -8.2% | 41.9% | ||
| Q2 24 | -18.3% | 41.2% |
净利率CTKBOSBC
| Q1 26 | — | 27.3% | ||
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 10.3% | ||
| Q2 25 | -12.2% | 29.0% | ||
| Q1 25 | -27.5% | 27.1% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | 32.3% | ||
| Q2 24 | -22.4% | 30.9% |
每股收益（稀释后）CTKBOSBC
| Q1 26 | — | $0.48 | ||
| Q4 25 | — | $0.53 | ||
| Q3 25 | — | $0.18 | ||
| Q2 25 | — | $0.48 | ||
| Q1 25 | — | $0.43 | ||
| Q4 24 | — | $0.42 | ||
| Q3 24 | — | $0.50 | ||
| Q2 24 | — | $0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $115.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $893.3M |
| 总资产 | $461.5M | $6.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBOSBC
| Q1 26 | — | $115.7M | ||
| Q4 25 | $90.9M | $124.0M | ||
| Q3 25 | $93.3M | $116.5M | ||
| Q2 25 | $75.5M | $141.8M | ||
| Q1 25 | $95.3M | $256.1M | ||
| Q4 24 | $98.7M | $99.3M | ||
| Q3 24 | $162.3M | $115.8M | ||
| Q2 24 | $177.9M | $120.9M |
股东权益CTKBOSBC
| Q1 26 | — | $893.3M | ||
| Q4 25 | $341.7M | $896.8M | ||
| Q3 25 | $378.6M | $866.7M | ||
| Q2 25 | $377.6M | $718.6M | ||
| Q1 25 | $379.6M | $694.5M | ||
| Q4 24 | $395.7M | $671.0M | ||
| Q3 24 | $385.5M | $661.4M | ||
| Q2 24 | $389.1M | $619.3M |
总资产CTKBOSBC
| Q1 26 | — | $6.8B | ||
| Q4 25 | $461.5M | $6.9B | ||
| Q3 25 | $494.9M | $7.0B | ||
| Q2 25 | $493.3M | $5.7B | ||
| Q1 25 | $482.6M | $5.7B | ||
| Q4 24 | $499.5M | $5.6B | ||
| Q3 24 | $491.2M | $5.7B | ||
| Q2 24 | $483.7M | $5.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBOSBC
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $122.3M | ||
| Q3 25 | $-3.9M | $35.9M | ||
| Q2 25 | $108.0K | $24.2M | ||
| Q1 25 | $-125.0K | $17.8M | ||
| Q4 24 | $2.0M | $131.5M | ||
| Q3 24 | $13.2M | $48.5M | ||
| Q2 24 | $6.2M | $11.6M |
自由现金流CTKBOSBC
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $117.8M | ||
| Q3 25 | $-4.6M | $34.7M | ||
| Q2 25 | $-1.5M | $23.5M | ||
| Q1 25 | $-974.0K | $16.2M | ||
| Q4 24 | $1.1M | $120.7M | ||
| Q3 24 | $12.2M | $46.2M | ||
| Q2 24 | $5.2M | $8.7M |
自由现金流率CTKBOSBC
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 123.7% | ||
| Q3 25 | -8.7% | 36.2% | ||
| Q2 25 | -3.2% | 31.2% | ||
| Q1 25 | -2.3% | 22.2% | ||
| Q4 24 | 1.9% | 165.0% | ||
| Q3 24 | 23.7% | 64.9% | ||
| Q2 24 | 11.0% | 12.3% |
资本支出强度CTKBOSBC
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 4.7% | ||
| Q3 25 | 1.3% | 1.3% | ||
| Q2 25 | 3.5% | 1.1% | ||
| Q1 25 | 2.0% | 2.2% | ||
| Q4 24 | 1.6% | 14.7% | ||
| Q3 24 | 2.0% | 3.3% | ||
| Q2 24 | 2.3% | 4.2% |
现金转化率CTKBOSBC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 3.64× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 2.11× | ||
| Q2 24 | — | 0.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
OSBC
| Net Interest Income | $81.1M | 87% |
| Noninterest Income | $12.6M | 13% |
